Similar to the PPAR-α, the CPT1A proteins increased (p < 0.0001) in the hepatic tissues of the NAFLD group in comparison to the control group (Figure 3(a)). Here, CPT1A is linked to metabolic dysfunction-associated steatotic liver disease.